Doctor profile · Federal record
Dr. Samantha Digruccio, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Saint Louis, MO
- NPI 1053831107
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4921 Parkview Pl, Div Im Endocrinology, Ste 13B
Saint Louis, MO 631101032
(314) 362-3500
fax (314) 230-1119 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- June 2017 — 9 yrs on file
- Profile last updated
- April 17, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Missouri #2019020906
- Medicaid
- MO #200061287
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053831107. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
53
Distinct HCPCS
3
Medicare allowed
$3,406
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 26 | 22 | $124 | |
83036 |
Hemoglobin a1c level | 15 | 13 | $10 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 12 | 11 | $3 |
In context: peer comparison
Among 33 peers in Saint Louis Endocrinology, Diabetes & Metabolism Physician, average services per provider: 421. This provider delivers 0.1× the peer median.Open Payments
Industry payments received
All-time total
$22
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 1 | $21.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
344
Patients
22
Total drug cost
$213,257
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 44 | 11 | $726 |
| Trulicity (Dulaglutide) | Brand | 43 | 0 | $59,331 |
| Metformin Hcl | Generic | 42 | 0 | $382 |
| Jardiance (Empagliflozin) | Brand | 40 | 0 | $37,006 |
| Ozempic (Semaglutide) | Brand | 33 | 11 | $47,658 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 32 | 0 | $13,567 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 30 | 0 | $33,586 |
| Lisinopril | Generic | 25 | 0 | $81 |
| Ultra-Fine Short Pen Needle (Pen Needle, Diabetic) | Brand | 18 | 0 | $1,434 |
| Pentips (Pen Needle, Diabetic) | Brand | 13 | 0 | $283 |
Hospital affiliations
Frequently asked questions
What is Dr. Samantha Digruccio's medical specialty?
Dr. Samantha Digruccio practices Endocrinology, Diabetes & Metabolism Physician in Saint Louis, MO.
Where does Dr. Samantha Digruccio practice?
Dr. Samantha Digruccio practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 3143623500.
What is Dr. Samantha Digruccio's NPI?
Dr. Samantha Digruccio's National Provider Identifier (NPI) is 1053831107, issued by NPPES.
Does Dr. Samantha Digruccio accept Medicare assignment?
Yes. Dr. Samantha Digruccio accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samantha Digruccio commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.